Investor profile
Vivo Capital
Crossover Fund · United States
Portfolio companies
Source-backed examples · Includes past investments and exits
No separately checked portfolio examples on file.
People at Vivo Capital
Find team membersRecent tracked investments
Announcement dates · Amounts are total round sizes, not this investor’s individual investment
| Company | Round size | Stage | Sector | Announced | Source |
|---|---|---|---|---|---|
| Immunocan | $35M | Series A | HealthTech | 2026-05-13 |